心臟帮浦设备市场报告：2031 年趋势、预测与竞争分析

预计未来全球心臟帮浦设备市场将在医院和心臟中心市场迎来机会。预计到 2031 年，全球心臟帮浦设备市场规模将达到 80 亿美元，2025 年至 2031 年的复合年增长率为 20.3%。该市场的主要驱动因素是肥胖症盛行率的上升、该设备在心臟移植手术中的使用增加以及心血管疾病的发生率上升。

• Lucintel 表示，根据类型，预测期内植入式装置将继续占据较大的市场份额，这是因为不适合进行心臟移植的心臟衰竭患者的需求不断增长。
• 在最终用途类别中，医院预计将继续成为主要部分，因为大量的外科手术、心血管疾病的增加以及熟练专家的可用性正在推动医院对心臟泵设备的需求。
• 从地区来看，预计北美将在预测期内继续成为最大的地区，因为该地区人口心臟病患病率高、医疗保健基础设施强大且有主要企业存在。

心臟帮浦设备市场的策略性成长机会

与心臟泵设备市场相关的各种应用中存在着许多策略性成长机会。了解这些机会对于希望积极参与心血管护理和技术变革的相关人员来说非常重要。

• 扩展到新兴市场：由于心臟病发病率上升导致医疗保健投资增加，扩展到新兴市场具有良好的成长前景。为有需求的地区开发具有成本效益且易于获得的产品可以开拓新的市场。
• 整合数位健康技术：将数位健康技术整合到辅助人工心臟中有可能改善患者的监测和管理。远端监控不仅可以改善设备功能，还可以透过即时资料分析来改善临床结果，从而创造新的市场。
• 以患者为中心的设计开发：专注于以患者为中心的设计有助于推动心血管帮浦的采用。提高患者舒适度、易用性和与生活方式无缝融合的创新将成为需求的主要驱动力，并可以提高患者对治疗的依从性。
• 生物相容性发展：生物相容性心臟帮浦的发展将创造新的成长机会。这项技术减少了併发症的可能性并延长了设备的使用寿命，使其对患者和医疗保健提供者都更具吸引力并扩大了市场。
• 伙伴关係与协作：製造商、研究机构和医疗服务提供者之间的策略伙伴关係正在加速创新和市场进入。此次合作不仅促进了技术进步，也扩大了市场。

这些机会显示心臟帮浦设备市场有着光明的成长前景。相关人员可以利用新兴趋势和策略性倡议来产生创新，改善患者健康状况并可能创造新的市场。

心臟帮浦设备市场驱动因素与挑战

各种驱动因素​​和挑战影响心臟帮浦设备市场的发展和成长。了解这些因素对于开拓这个市场并解决心臟护理中的关键问题至关重要。

推动心臟帮浦设备市场发展的因素如下：

1. 技术进步：由于技术进步，例如具有高度生物相容性的下一代 LVAD（左心室辅助装置），市场正在不断扩大。这些改进使得这些设备的性能更加出色，从而导致需求随着用户采用率的提高而增加。

2. 心血管疾病盛行率上升：全球心血管疾病盛行率不断上升，导致全球心臟帮浦的市场占有率不断增加。随着越来越多的患者寻求更好的护理，需要先进的心臟泵技术。

3. 监管部门的核准和支持：监管部门的核准以及对新型心臟泵技术的支持正在加速其市场发展。结合简化的核准流程，这加快了创新设备进入诊所和医院的速度，扩大了治疗选择。

4. 研发投资：增加研发支出有助于创新心臟帮浦技术的发展。这笔资金筹措鼓励开发更有效率的设备并有助于推动市场发展。

5. 提高意识和教育：病人和医疗保健专业人员对心臟病学和先进方法的了解不断增加，导致对心血管帮浦的需求增加。患者和医疗保健提供者的理解不断提高，推动了这些技术的采用。

心臟帮浦设备市场面临的挑战包括：

1. 先进设备高成本：先进心臟帮浦设备的高成本对市场成长构成了挑战。昂贵的技术可能会限制其可近性和采用率，尤其是在医疗预算较低的地区。

2. 监管和报销障碍：製造商经常难以应对该行业面临的监管和报销障碍。复杂的核准流程和报销问题可能会减缓市场进入进程并对设备接受率产生不利影响。

3. 设备併发症和管理：感染疾病和设备故障等问题可能导致与心臟帮浦相关的医疗併发症，使患者照护和安全问题变得复杂。解决这些问题对于提高设备可靠性和临床结果将变得越来越重要。

多种驱动因素​​和挑战正在影响心臟帮浦设备市场的发展和成长。解决这些因素将有助于相关人员驾驭市场，同时有助于改善心血管护理。

目录

第一章执行摘要

第二章全球心臟帮浦设备市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球心臟帮浦设备市场趋势（2019-2024）及预测（2025-2031）
• 全球心臟帮浦设备市场类型
  • 植入式心臟帮浦装置
  • 体外心臟帮浦装置
• 全球心臟帮浦设备市场（依产品类型）
  • 心室辅助装置（VAD）
  • 全人工心臟（TAH）
  • 主动脉内球囊帮浦（IABP）
  • 体外膜氧合（ECMO）
• 全球心臟帮浦设备市场（依最终用途划分）
  • 医院
  • 心臟中心
  • 其他的

第四章2019年至2031年区域市场趋势与预测分析

• 区域心臟帮浦设备市场
• 北美心臟帮浦设备市场
• 欧洲心臟帮浦设备市场
• 亚太心臟帮浦设备市场
• 世界其他地区心臟帮浦设备市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球心臟帮浦设备市场成长机会（按类型）
  • 全球心臟帮浦设备市场成长机会（依产品类型）
  • 全球心臟帮浦设备市场最终用途的成长机会
  • 区域心臟帮浦设备市场的成长机会
• 全球心臟帮浦设备市场的新趋势
• 战略分析
  • 新产品开发
  • 全球心臟帮浦设备市场产能扩张
  • 全球心臟帮浦设备市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业简介

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

The future of the global heart pump device market looks promising with opportunities in the hospital and cardiac center markets. The global heart pump device market is expected to reach an estimated $8 billion by 2031 with a CAGR of 20.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of obesity, the rising use of this device in heart transplant procedures, and the escalating incidence of cardiovascular disorders.

• Lucintel forecasts that, Within the type category, implanted will remain the larger segment over the forecast period due to its rising need among patients suffering from heart failure who are not eligible for a heart transplant.
• Within the end-use category, hospitals will remain the larger segment due to the increased need for heart pump devices in this setting owing to the number of surgeries being done, growing incidences of cardiovascular disorders, and availability of qualified specialists.
• In terms of regions, North America will remain the largest region over the forecast period due to high heart disease rates among the population, the existence of robust healthcare infrastructure, and the presence of key players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Heart Pump Device Market

The heart pump device market is evolving with emerging trends that mirror advancements in technology, patient care, and changes within the market itself. Understanding these trends can therefore provide insight into how this industry has changed over time and where it may be headed next in terms of innovative heart pumps.

• Miniaturization of Devices: There is a trend toward miniaturization and efficiency improvement with smaller devices. This can be attributed to advances in materials science and engineering that make procedures less invasive, thus enhancing patients' comfort. Small implants also allow better integration into patients' lives and enable them to move around freely without any hassle.
• Integration with Digital Health: This trend has seen heart pumps integrated into digital health technologies. Remote monitoring along with data analytics has greatly improved device management and patient care. This opens up real-time assessment of both device performance and patient health, thereby leading to prompt actions or targeted curative procedures through such insights.
• Improved Biocompatibility: Advances in material science have led to improved biocompatibility of ventricular assist devices. New materials and coatings have reduced the risks of complications and resulted in better long-term performance of devices. Ensuring biocompatibility is crucial for patient safety and device longevity.
• Focus on Patient-Centric Designs: There has been an increasing focus on designing heart pumps with patients' comfort and lifestyle in mind. These include ergonomic designs, reduced device profiles, and user-friendly interfaces. This trend aims to improve how patients experience healthcare services and their compliance with therapies.
• Expansion into Emerging Markets: The heart pump market is entering emerging markets due to increased healthcare investments and the growing incidence of cardiovascular diseases. In these regions, firms are developing cost-effective solutions that enhance accessibility and affordability concerning heart pump technologies.

These emerging trends are redefining the heart pump device market by improving device functionality, enhancing patient outcomes, and expanding market reach. The shift toward miniaturization, digital integration, or patient-centric design characterizes a broader transformation toward more effective and accessible cardiovascular care.

Recent Developments in the Heart Pump Device Market

In recent times there have been significant advancements within the heart pump device market due to technological advancements made as well as regulatory approvals granted thereby expanding the industry's geographical footprint. Such developments are defining future treatment approaches for cardiovascular complications globally thus leading to improved patient results.

• Next-Generation LVADs: Significant progress has been achieved by introducing next-generation Left Ventricular Assist Devices (LVADs) which are more durable than ever before leading to fewer complications. Through this, these devices offer better clinical outcomes for patients while extending their lifespan addressing key problems concerning HF therapy at hand.
• FDA Approvals for Innovative Designs: Recently FDA-approved new designs for artificial hearts have widened treatment options for many patients who need them across America. Among other things, some innovations include wireless monitoring systems such as those with advanced features like the one that can detect some chemicals contributing to better patient management and care. Emergence of Local Manufacturers:
• In developing markets, local manufacturing has resulted in cheap heart pumps. Such a trend makes advanced cardiovascular technologies more accessible and affordable, particularly for high HF disease burden regions.
• Technological Advances in Biocompatibility: With advancements in materials & coatings, the biocompatibility of artificial hearts is enhanced. New methods are reducing risks of complications and ensuring longer functioning as they are crucial for long-term patient care.
• Increased Investment in R&D: Increased R&D investment stimulates innovation in heart pump technology. Firms are striving to develop more efficient, durable, and patient-friendly units thereby pushing the limits of current artificial heart capabilities.

Through technology enhancement, expanded access or improved patient outcomes, these developments have significantly impacted on heart pump device market. The ongoing advances indicate a commitment towards addressing HF challenge as well as advancing cardiovascular care globally for every individual suffering from it.

Strategic Growth Opportunities for Heart Pump Device Market

The numerous strategic growth opportunities exist within various applications related to heart pump device market. Understanding these opportunities becomes important for stakeholders who want to participate actively in changing landscape of cardiovascular treatment and technology.

• Expansion into Emerging Markets: Going to emerging markets provides excellent growth prospects due to increased investments in healthcare along with higher incidence of cardiac diseases. This can lead to new markets expansion by developing cost effective and accessible products for those areas where demand exists.
• Integration of Digital Health Technologies: There is an opportunity to integrate digital health technologies with ventricular assist devices that could improve patients' monitoring and management. Remote monitoring enables device function as well as better clinical results through real-time data analytics hence creating new marketplaces.
• Patient-Centric Designs Development: A focus on patient-centric designs can encourage the uptake of cardiovascular pumps. Innovations that promote patients' comfort, ease of use, and seamless integration with their way of life can be major drivers of demand and enhance patient adherence to treatment.
• Biocompatibility Developments: Developing heart pumps that have better biocompatibility creates new opportunities for growth. This technology lowers the chance of complications occurring and increases the lifespan of the devices, making them more attractive to patients and providers alike hence creating wider markets.
• Partnerships and Collaborations: Strategic partnerships between manufacturers, research institutions, and healthcare providers can accelerate innovation as well as market entry. These collaborations result in advancement in technologies as well as expansive market coverage.

These opportunities reveal a promising future for growth within the heart pump device market. Stakeholders may utilize emerging trends along with strategic initiatives to create innovations and improve health outcomes for their patients thereby creating new markets.

Heart Pump Device Market Driver and Challenges

Different drivers and challenges influence the development and growth of the heart pump device market. Comprehending these elements is vital to traversing this marketplace while addressing critical problems in cardiac care delivery.

The factors responsible for driving the heart pump device market include:

1. Technological Advancements: Market expansion is caused by technological advancements such as next generation LVADs (Left Ventricular Assist Devices) which have better biocompatibility. Such improvements make these devices perform better thus contributing to increased adoption rates by users leading to high demands.

2. Rising Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases worldwide has grown resulting in increased heart pump market share globally. Increased numbers of patients are seeking better treatments for their lives thus needing advanced heart pumping technologies.

3. Regulatory Approvals and Support: Regulatory approvals together with support for novel heart pump technologies are driving overall market development at an increasing pace. Favorable legislation coupled with streamlined approval processes help quicken introduction of innovative gadgets into clinics or hospitals expanding treatment options.

4. Investment in Research and Development: Rising expenditure on R&D is contributing towards the growth of innovative heart pump technologies. This funding type facilitates the creation of devices that are more efficient and effective thus boosting market development.

5. Growing Awareness and Education: Improved patient as well as health professional knowledge about heart disease and advanced approach has led to increased demand for cardiovascular pumps. Greater understanding among patients and healthcare providers supports the adoption of such technologies.

Challenges in the heart pump device market are:

1. High Costs of Advanced Devices: The high costs associated with advanced heart pump devices pose a challenge for market growth. Expensive technologies can limit accessibility and adoption, particularly in regions with lower healthcare budgets.

2. Regulatory and Reimbursement Hurdles: Manufacturers often struggle to navigate their way through regulatory as well as reimbursement hurdles facing this industry. Complex approval processes coupled with reimbursement issues may slow down the process of entering the market thereby negatively influencing device acceptance rates.

3. Device Complications and Management: Problems like infections or device malfunctioning among others result in medical complications associated with cardiac pumps which then put pressure on patient care and safety issues. Fixing these problems will become increasingly important for enhancing clinical outcomes along with device reliability.

Several drivers or challenges impact the heart pump device market leading to its development or growth. These factors should be addressed by stakeholders so that they successfully navigate across the market while contributing towards improved cardiovascular care.

List of Heart Pump Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart pump device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart pump device companies profiled in this report include-

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

Heart Pump Device by Segment

The study includes a forecast for the global heart pump device market by type, product type, end use, and region.

Heart Pump Device Market by Type [Analysis by Value from 2019 to 2031]:

• Implanted Heart Pump Devices
• Extracorporeal Heart Pump Devices

Heart Pump Device Market by Product Type [Analysis by Value from 2019 to 2031]:

• Ventricular Assist Devices (VADs)
• Total Artificial Hearts (TAHs)
• Intra-Aortic Balloon Pumps (IABPs)
• Extracorporeal Membrane Oxygenation (ECMO)

Heart Pump Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Cardiac Centers
• Others

Heart Pump Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Heart Pump Device Market

The market for heart pump devices is moving rapidly due to technological breakthroughs and the rise in demand for effective cardiovascular treatment. Significant strides have been made toward innovation and market growth in the U.S., China, Germany, India, and Japan. These improvements are part of a continued effort to combat heart failure and enhance patient outcomes with advanced cardiac devices.

• United States: Recent developments in the U.S. heart pump device market include the FDA's approval of a new generation of Left Ventricular Assist Devices (LVADs) that are more durable and have fewer complications. Innovations from companies like Abbott and Medtronic are leading the way with better integration and remote monitoring capabilities. These improvements aim to enhance patients' quality of life and broaden the use of heart pumps in treating advanced stages of heart failure.
• China: In China, investment in cardiovascular healthcare, coupled with technological advances, has contributed to growth within the heart pump device market. Chinese firms like MicroPort and LifeTech are developing affordable heart pumps tailored to their local markets. Such innovations make it easier for people to access affordable heart pumps, thus helping to control escalating disease burdens.
• Germany: On a European scale, Germany plays a leading role in heart pump technology advancement, with recent innovations focusing on miniature versions that can be implanted beneath a patient's skin. Companies like Berlin Heart and Fresenius are developing new models that guarantee improved patient comfort and longer durability. This development stems from Germany's strong healthcare infrastructure and increased R&D efforts, establishing it as an innovation leader for heart pumps.
• India: The heart pump device market in India is evolving based on affordability and accessibility concerns. Domestic manufacturers are creating cost-effective alternatives for coronary artery disease, which is prevalent among a larger population segment characterized by inadequate access to these devices given its purchasing power parity compared to other countries. The government's approach, along with relationships formed with foreign organizations, has aided in the introduction of modern technologies aimed at advancing care and improving treatment outcomes for patients with cardiac failure.
• Japan: Japan is making strides in heart pump technology with a focus on next-generation devices that offer enhanced biocompatibility and functionality. Compactness, durability, and heart pumps for the elderly population are among the critical concerns pursued by companies like Terumo and Japan Lifeline. These initiatives are improving patient outcomes while widening the application of cardiac support devices for heart failure management.

Features of the Global Heart Pump Device Market

Market Size Estimates: Heart pump device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Heart pump device market size by type, product type, end use, and region in terms of value ($B).

Regional Analysis: Heart pump device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, product types, end uses, and regions for the heart pump device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart pump device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the heart pump device market by type (implanted heart pump devices and extracorporeal heart pump devices), product type (ventricular assist devices (VADs), total artificial hearts (TAHs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO)), end use (hospitals, cardiac centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Pump Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Heart Pump Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Heart Pump Device Market by Type
  • 3.3.1: Implanted Heart Pump Devices
  • 3.3.2: Extracorporeal Heart Pump Devices
• 3.4: Global Heart Pump Device Market by Product Type
  • 3.4.1: Ventricular Assist Devices (VADs)
  • 3.4.2: Total Artificial Hearts (TAHs)
  • 3.4.3: Intra-Aortic Balloon Pumps (IABPs)
  • 3.4.4: Extracorporeal Membrane Oxygenation (ECMO)
• 3.5: Global Heart Pump Device Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Cardiac Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Heart Pump Device Market by Region
• 4.2: North American Heart Pump Device Market
  • 4.2.1: North American Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.2.2: North American Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.3: European Heart Pump Device Market
  • 4.3.1: European Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.3.2: European Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.4: APAC Heart Pump Device Market
  • 4.4.1: APAC Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.4.2: APAC Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.5: ROW Heart Pump Device Market
  • 4.5.1: ROW Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.5.2: ROW Market by End Use: Hospitals, Cardiac Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Heart Pump Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Heart Pump Device Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Heart Pump Device Market by End Use
  • 6.1.4: Growth Opportunities for the Global Heart Pump Device Market by Region
• 6.2: Emerging Trends in the Global Heart Pump Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Heart Pump Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Pump Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: ABIOMED
• 7.3: CorWave
• 7.4: LivaNova
• 7.5: Berlin Heart
• 7.6: SynCardia Systems
• 7.7: Jarvik Heart
• 7.8: BiVACOR
• 7.9: Leviticus Cardio
• 7.10: Evaheart